These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 36177059)

  • 1. The Potential In Vitro Inhibitory Effects of Neurokinin-1 Receptor (NK-1R) Antagonist, Aprepitant, in Osteosarcoma Cell Migration and Metastasis.
    Alsaeed MA; Ebrahimi S; Alalikhan A; Hashemi SF; Hashemy SI
    Biomed Res Int; 2022; 2022():8082608. PubMed ID: 36177059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substance P accelerates the progression of human esophageal squamous cell carcinoma via MMP-2, MMP-9, VEGF-A, and VEGFR1 overexpression.
    Mohammadi F; Javid H; Afshari AR; Mashkani B; Hashemy SI
    Mol Biol Rep; 2020 Jun; 47(6):4263-4272. PubMed ID: 32436041
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of NK-1R using aprepitant suppresses inflammatory response in rheumatoid arthritis fibroblast-like synoviocytes.
    Liu X; Zhu Y; Zheng W; Qian T; Wang H; Hou X
    Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1628-1634. PubMed ID: 31010320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential in vitro therapeutic effects of targeting SP/NK1R system in cervical cancer.
    Mozafari M; Ebrahimi S; Darban RA; Hashemy SI
    Mol Biol Rep; 2022 Feb; 49(2):1067-1076. PubMed ID: 34766230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of substance P and its specific antagonist (aprepitant) on the expression of MMP-2, MMP-9, VEGF, and VEGFR in ovarian cancer cells.
    Momen Razmgah M; Ghahremanloo A; Javid H; AlAlikhan A; Afshari AR; Hashemy SI
    Mol Biol Rep; 2022 Oct; 49(10):9307-9314. PubMed ID: 35960409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Repurposing of Non-Peptide Neurokinin-1 Receptor Antagonists as Antitumor Drugs: An Urgent Challenge for Aprepitant.
    Coveñas R; Rodríguez FD; Robinson P; Muñoz M
    Int J Mol Sci; 2023 Nov; 24(21):. PubMed ID: 37958914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SP/NK1R system regulates carcinogenesis in prostate cancer: Shedding light on the antitumoral function of aprepitant.
    Ebrahimi S; Mirzavi F; Aghaee-Bakhtiari SH; Hashemy SI
    Biochim Biophys Acta Mol Cell Res; 2022 May; 1869(5):119221. PubMed ID: 35134443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurokinin-1 Receptor Antagonists as a Potential Novel Therapeutic Option for Osteosarcoma Patients.
    Robinson P; Rosso M; Muñoz M
    J Clin Med; 2023 Mar; 12(6):. PubMed ID: 36983138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The substance P/ neurokinin-1 receptor signaling pathway mediates metastasis in human colorectal SW480 cancer cells.
    Golestaneh M; Firoozrai M; Javid H; Hashemy SI
    Mol Biol Rep; 2022 Jun; 49(6):4893-4900. PubMed ID: 35429316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigation of the Role of Neurokinin-1 Receptor Inhibition Using Aprepitant in the Apoptotic Cell Death through PI3K/Akt/NF-
    Ghahremanloo A; Javid H; Afshari AR; Hashemy SI
    Biomed Res Int; 2021; 2021():1383878. PubMed ID: 34395609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurokinin-1 receptor antagonist aprepitant regulates autophagy and apoptosis via ROS/JNK in intrahepatic cholangiocarcinoma.
    Yang Y; Cao X; Wang Y; Wu X; Zhou P; Miao L; Deng X
    Liver Int; 2024 Jul; 44(7):1651-1667. PubMed ID: 38554043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The NK-1R Antagonist Aprepitant Prevents LPS-Induced Oxidative Stress and Inflammation in RAW264.7 Macrophages.
    Zhao XN; Bai ZZ; Li CH; Sheng CL; Li HY
    Drug Des Devel Ther; 2020; 14():1943-1952. PubMed ID: 32546961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The novel synthesized 6-fluoro-(3-fluorophenyl)-4-(3-methoxyanilino)quinazoline (LJJ-10) compound exhibits anti-metastatic effects in human osteosarcoma U-2 OS cells through targeting insulin-like growth factor-I receptor.
    Chen KT; Hour MJ; Tsai SC; Chung JG; Kuo SC; Lu CC; Chiu YJ; Chuang YH; Yang JS
    Int J Oncol; 2011 Sep; 39(3):611-9. PubMed ID: 21667022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-κB axis: Shedding new light on resistance to Aprepitant.
    Bashash D; Safaroghli-Azar A; Bayati S; Razani E; Pourbagheri-Sigaroodi A; Gharehbaghian A; Momeny M; Sanjadi M; Rezaie-Tavirani M; Ghaffari SH
    Int J Biochem Cell Biol; 2018 Oct; 103():105-114. PubMed ID: 30145367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kaempferol suppresses cell metastasis via inhibition of the ERK-p38-JNK and AP-1 signaling pathways in U-2 OS human osteosarcoma cells.
    Chen HJ; Lin CM; Lee CY; Shih NC; Peng SF; Tsuzuki M; Amagaya S; Huang WW; Yang JS
    Oncol Rep; 2013 Aug; 30(2):925-32. PubMed ID: 23708932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Neurokinin-1 Receptor Is a Target in Pediatric Rhabdoid Tumors.
    Kolorz J; Demir S; Gottschlich A; Beirith I; Ilmer M; Lüthy D; Walz C; Dorostkar MM; Magg T; Hauck F; von Schweinitz D; Kobold S; Kappler R; Berger M
    Curr Oncol; 2021 Dec; 29(1):94-110. PubMed ID: 35049682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aprepitant inhibits the development and metastasis of gallbladder cancer via ROS and MAPK activation.
    Cao X; Yang Y; Zhou W; Wang Y; Wang X; Ge X; Wang F; Zhou F; Deng X; Miao L
    BMC Cancer; 2023 May; 23(1):471. PubMed ID: 37221457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SP/NK1R system promotes the proliferation of breast cancer cells through NF-κB-mediated inflammatory responses.
    Jafarinezhad S; Assaran Darban R; Javid H; Hashemy SI
    Cell Biochem Biophys; 2023 Dec; 81(4):787-794. PubMed ID: 37740877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor activity of neurokinin-1 receptor antagonists in MG-63 human osteosarcoma xenografts.
    Muñoz M; Berger M; Rosso M; Gonzalez-Ortega A; Carranza A; Coveñas R
    Int J Oncol; 2014 Jan; 44(1):137-46. PubMed ID: 24190675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vitro anti-cancer synergy of neurokinin-1 receptor antagonist, aprepitant, and 5-aminolevulinic acid in glioblastoma.
    Ebrahimi S; Mirzavi F; Hashemy SI; Khaleghi Ghadiri M; Stummer W; Gorji A
    Biofactors; 2023; 49(4):900-911. PubMed ID: 37092793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.